Insomnia — difficulty falling asleep, staying asleep, or sleeping restoratively — is more common in women than in men, and research suggests this disparity increases after age 35. For many women, the timing of sleep changes corresponds with hormonal shifts in the lead-up to perimenopause and through the menopausal transition. Understanding the relationship between hormones and sleep architecture can help frame this experience within a biological context rather than as a personal deficiency.
It’s important to acknowledge that “hormonal insomnia” is an informal term rather than a clinical diagnosis. Insomnia has multiple contributing factors, and hormonal changes are one of several potential elements. A healthcare provider can help identify what’s driving sleep difficulties in your specific situation.
What Research Shows About Hormones and Sleep After 35
Research from the American Sleep Association and reproductive health literature indicates that estrogen and progesterone both influence sleep in distinct ways, and their fluctuation and decline during perimenopause are associated with increased sleep difficulties. Studies suggest that perimenopausal women report significantly higher rates of insomnia symptoms compared to premenopausal women of similar age, and that hormonal factors are among the contributing variables.
How Estrogen Influences Sleep Architecture
Estrogen plays multiple roles in sleep regulation. Research suggests it supports serotonin production — a neurotransmitter involved in mood and sleep — and may influence melatonin receptor sensitivity. Estrogen is also associated with regulation of body temperature, and as estrogen fluctuates in perimenopause, the resulting vasomotor symptoms (hot flashes and night sweats) are a major cause of sleep disruption for many women.
REM Sleep and Hormonal Changes
Some research indicates that estrogen may support REM (rapid eye movement) sleep — the sleep stage associated with emotional processing and cognitive consolidation. As estrogen declines, the structure of sleep may shift, with some women experiencing more fragmented or lighter sleep and less time in deeper stages. These changes in sleep architecture can contribute to the experience of sleep that doesn’t feel as restorative, even when total sleep time appears adequate.
The Estrogen-Serotonin Connection
Estrogen’s influence on serotonin pathways may partly explain why mood and sleep difficulties often appear together during perimenopause. Serotonin is a precursor to melatonin and also plays a role in regulating the sleep-wake cycle. This biochemical connection is one reason why some non-hormonal treatments for perimenopausal sleep difficulties — including certain antidepressants — have shown effectiveness for some women, by targeting serotonin pathways. If you’ve been experiencing both sleep changes and mood shifts, discussing these together with your provider can help clarify whether they’re related.
Progesterone’s Role in Sleep Quality
Progesterone has sedating properties that support sleep — it’s one reason many women feel particularly sleepy during the luteal phase of their cycle (when progesterone is highest) and during early pregnancy. Progesterone metabolizes to a compound that acts on GABA receptors — the brain’s primary calming neurotransmitter system — which is thought to explain this sleep-promoting effect.
As progesterone levels decline in perimenopause, this natural calming effect diminishes, which may make falling asleep more difficult and reduce the depth of sleep for some women. This is one reason why some providers consider progesterone supplementation in the context of perimenopausal sleep difficulties, though individual responses and medical appropriateness vary. Understanding how hormonal insomnia fits within the broader landscape of sleep after 35 can help frame provider conversations productively.
Non-Hormonal Approaches With Research Support
Cognitive Behavioral Therapy for Insomnia (CBT-I) has the strongest evidence base among non-pharmacological approaches for insomnia and is recommended as a first-line treatment by several clinical guidelines, including those from the American College of Physicians. CBT-I addresses the thought patterns, behaviors, and sleep environment factors that perpetuate insomnia, and research suggests its benefits may outlast those of sleep medications for some individuals.
Sleep Restriction and Stimulus Control
Two core components of CBT-I — sleep restriction (temporarily limiting time in bed to build sleep pressure) and stimulus control (strengthening the mental association between bed and sleep) — can feel counterintuitive but have substantial research support. Working with a therapist trained in behavioral sleep medicine, or using evidence-based digital CBT-I programs, provides the most structured approach.
Mindfulness-Based Stress Reduction
Mindfulness-based interventions have been studied in relation to perimenopausal symptoms including sleep, with some research showing modest improvements in sleep quality and insomnia severity. These approaches may be particularly relevant for the rumination and hyperarousal that often accompany insomnia, and can be a useful complement to other sleep-supporting strategies.
Medical Options to Discuss With Your Provider
Several medical approaches have evidence for sleep difficulties related to perimenopause:
- Hormone therapy (HT): Research consistently shows benefits for vasomotor symptoms that are disrupting sleep. Whether HT is appropriate depends on your health history, symptom severity, and personal preferences — a conversation with your gynecologist or menopause specialist can clarify this.
- Non-hormonal prescription options: Low-dose antidepressants (in specific classes) have evidence for both vasomotor symptoms and mood-sleep overlap. Neurokinin receptor antagonists are a newer class with evidence for hot flashes. These aren’t the right fit for everyone, but expand the options available.
- Short-term sleep medications: In some situations, short-term use of prescription or over-the-counter sleep aids may be appropriate while addressing underlying factors. Long-term reliance on sleep aids — particularly older antihistamine-based products — is generally not recommended without medical guidance.
Frequently Asked Questions
How do I know if my insomnia is hormonal versus other causes?
Hormonal insomnia often presents alongside other perimenopausal symptoms — cycle changes, hot flashes, mood shifts — which can be a useful pattern to observe. However, insomnia can have multiple overlapping causes including anxiety, depression, sleep apnea, medications, and lifestyle factors. A provider can help sort out what’s driving your specific experience through a combination of symptom history, physical assessment, and sometimes sleep testing.
Can sleep apnea emerge after 35?
Sleep apnea is underdiagnosed in women and can emerge or worsen during perimenopause — research suggests that declining progesterone may reduce upper airway tone. Symptoms including snoring, waking gasping, unrefreshing sleep, and daytime fatigue despite adequate sleep time are worth discussing with your provider. A sleep study can assess whether sleep apnea is contributing to insomnia or fatigue.
Is it normal for sleep to be worse in the week before my period?
Many women report that sleep is most disrupted in the late luteal phase — the week before menstruation — when progesterone drops most rapidly. This pattern is common and relates to the withdrawal of progesterone’s calming effects. Tracking sleep in relation to your cycle can help identify this pattern and provide useful context for provider conversations.
Will my sleep improve after menopause?
Research suggests that sleep often stabilizes in postmenopause for many women as hormone levels become more consistent (even at lower levels) rather than fluctuating. However, individual patterns vary, and some women continue to experience sleep difficulties after menopause for reasons including sleep apnea, chronic insomnia patterns, and other health factors. Addressing sleep difficulties rather than waiting for natural resolution is generally the more effective approach.
Key Takeaways
- Insomnia rates increase in women after 35, with hormonal fluctuations in perimenopause playing a significant contributing role.
- Estrogen affects sleep architecture, serotonin pathways, and temperature regulation — its fluctuation can disrupt multiple aspects of sleep quality.
- Progesterone’s natural sedating effects decline in perimenopause, making sleep onset and maintenance more challenging for some women.
- CBT-I has the strongest evidence base for insomnia among non-pharmacological approaches and may be a useful starting point to discuss with your provider.
- If hormonal, mood, and sleep symptoms are occurring together, discussing them as a cluster with your gynecologist or a menopause specialist can lead to more comprehensive support.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.